The Immunology Market is expected to reach USD 254.23 Billion by 2032 and grow at a CAGR of 11.8%
Exposure to toxic chemicals, stress, dietary components, gut dysbiosis, and infections among various other environmental factors lead to a substantial number of patients affected by autoimmune diseases. Currently, autoimmune diseases are the third leading chronic illness in the U.S., and approximately 50 million people in the country have at least one form of autoimmune disease. For example, UK data, published by the University of Oxford in May 2023, population-based study that included 22.0 million individuals indicates that one in ten people is suffering from the autoimmune disorders.